TrialLeukemia & lymphoma2020

Randomized phase 1 study of sequential ("primed") vs. concurrent decitabine in combination with cladribine, cytarabine, G-CSF, and mitoxantrone (CLAG-M) in adults with newly diagnosed or relapsed/refractory acute myeloid leukemia (AML) or other high-grade myeloid neoplasm.

Raffaele Palmieri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.